James B Wetmore1, Heng Yan2, Yan Hu2, David T Gilbertson2, Jiannong Liu2. 1. Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, MN; Division of Nephrology, Hennepin County Medical Center, University of Minnesota, Minneapolis, MN. Electronic address: james.wetmore@hcmed.org. 2. Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, MN.
Abstract
BACKGROUND: Little is known about differences in the clinical course between patients receiving maintenance dialysis who do and do not withdraw from dialysis therapy. STUDY DESIGN: Case-control analysis. SETTING & PARTICIPANTS: US patients with Medicare coverage who received maintenance hemodialysis for 1 year or longer in 2008 through 2011. PREDICTORS: Comorbid conditions, hospitalizations, skilled nursing facility stays, and a morbidity score based on durable medical equipment claims. OUTCOME: Withdrawal from dialysis therapy. MEASUREMENTS: Rates of medical events, hospitalizations, skilled nursing facility stays, and a morbidity score. RESULTS: The analysis included 18,367 (7.7%) patients who withdrew and 220,443 (92.3%) who did not. Patients who withdrew were older (mean age, 75.3±11.5 [SD] vs 66.2±14.1 years) and more likely to be women and of white race, and had higher comorbid condition burdens. The odds of withdrawal among women were 7% (95% CI, 4%-11%) higher than among men. Compared to age 65 to 74 years, age 85 years or older was associated with higher adjusted odds of withdrawal (adjusted OR, 1.61; 95% CI, 1.54-1.68), and age 18 to 44 years with lower adjusted odds (adjusted OR, 0.36; 95% CI, 0.32-0.40). Blacks, Asians, and Hispanics were less likely to withdraw than whites (adjusted ORs of 0.36 [95% CI, 0.35-0.38], 0.47 [95% CI, 0.42-0.53], and 0.46 [95% CI, 0.44-0.49], respectively). A higher durable medical equipment claims-based morbidity score was associated with withdrawal, even after adjustment for traditional comorbid conditions and hospitalization; compared to a score of 0 (lowest presumed morbidity), adjusted ORs of withdrawal were 3.48 (95% CI, 3.29-3.67) for a score of 3 to 4 and 12.10 (95% CI, 11.37-12.87) for a score ≥7. Rates of medical events and institutionalization tended to increase in the months preceding withdrawal, as did morbidity score. LIMITATIONS: Results may not be generalizable beyond US Medicare patients; people who withdrew less than 1 year after dialysis therapy initiation were not studied. CONCLUSIONS: Women, older patients, and those of white race were more likely to withdraw from dialysis therapy. The period before withdrawal was characterized by higher rates of medical events and higher levels of morbidity.
BACKGROUND: Little is known about differences in the clinical course between patients receiving maintenance dialysis who do and do not withdraw from dialysis therapy. STUDY DESIGN: Case-control analysis. SETTING & PARTICIPANTS: US patients with Medicare coverage who received maintenance hemodialysis for 1 year or longer in 2008 through 2011. PREDICTORS: Comorbid conditions, hospitalizations, skilled nursing facility stays, and a morbidity score based on durable medical equipment claims. OUTCOME: Withdrawal from dialysis therapy. MEASUREMENTS: Rates of medical events, hospitalizations, skilled nursing facility stays, and a morbidity score. RESULTS: The analysis included 18,367 (7.7%) patients who withdrew and 220,443 (92.3%) who did not. Patients who withdrew were older (mean age, 75.3±11.5 [SD] vs 66.2±14.1 years) and more likely to be women and of white race, and had higher comorbid condition burdens. The odds of withdrawal among women were 7% (95% CI, 4%-11%) higher than among men. Compared to age 65 to 74 years, age 85 years or older was associated with higher adjusted odds of withdrawal (adjusted OR, 1.61; 95% CI, 1.54-1.68), and age 18 to 44 years with lower adjusted odds (adjusted OR, 0.36; 95% CI, 0.32-0.40). Blacks, Asians, and Hispanics were less likely to withdraw than whites (adjusted ORs of 0.36 [95% CI, 0.35-0.38], 0.47 [95% CI, 0.42-0.53], and 0.46 [95% CI, 0.44-0.49], respectively). A higher durable medical equipment claims-based morbidity score was associated with withdrawal, even after adjustment for traditional comorbid conditions and hospitalization; compared to a score of 0 (lowest presumed morbidity), adjusted ORs of withdrawal were 3.48 (95% CI, 3.29-3.67) for a score of 3 to 4 and 12.10 (95% CI, 11.37-12.87) for a score ≥7. Rates of medical events and institutionalization tended to increase in the months preceding withdrawal, as did morbidity score. LIMITATIONS: Results may not be generalizable beyond US Medicare patients; people who withdrew less than 1 year after dialysis therapy initiation were not studied. CONCLUSIONS:Women, older patients, and those of white race were more likely to withdraw from dialysis therapy. The period before withdrawal was characterized by higher rates of medical events and higher levels of morbidity.
Authors: Eric Weinhandl; Edward Constantini; Susan Everson; David Gilbertson; Suying Li; Craig Solid; Michael Anger; J Ganesh Bhat; Peter DeOreo; Mahesh Krishnan; Allen Nissenson; Doug Johnson; T Alp Ikizler; Franklin Maddux; John Sadler; Leanna Tyshler; Tom Parker; Brigitte Schiller; Barry Smith; Stan Lindenfeld; Allan J Collins Journal: Am J Kidney Dis Date: 2015-06 Impact factor: 8.860
Authors: Keturah R Faurot; Michele Jonsson Funk; Virginia Pate; M Alan Brookhart; Amanda Patrick; Laura C Hanson; Wendy Camelo Castillo; Til Stürmer Journal: Pharmacoepidemiol Drug Saf Date: 2014-10-21 Impact factor: 2.890
Authors: James B Wetmore; Jiannong Liu; Heidi S Wirtz; David T Gilbertson; Kerry Cooper; Kimberly M Nieman; Allan J Collins; Brian D Bradbury Journal: Clin J Am Soc Nephrol Date: 2016-06-07 Impact factor: 8.237
Authors: Wim van Biesen; Moniek W M van de Luijtgaarden; Edwina A Brown; Jean-Pierre Michel; Barbara C van Munster; Kitty J Jager; Sabine N van der Veer Journal: Nephrol Dial Transplant Date: 2015-08-12 Impact factor: 5.992
Authors: Joy Chieh-Yu Chen; Bjorg Thorsteinsdottir; Lisa E Vaughan; Molly A Feely; Robert C Albright; Macaulay Onuigbo; Suzanne M Norby; Christy L Gossett; Margaret M D'Uscio; Amy W Williams; John J Dillon; LaTonya J Hickson Journal: Clin J Am Soc Nephrol Date: 2018-07-19 Impact factor: 8.237
Authors: James B Wetmore; Charles A Herzog; Anne Sexter; David T Gilbertson; Jiannong Liu; Scott E Kasner Journal: Am J Kidney Dis Date: 2020-05-28 Impact factor: 8.860
Authors: Yumeng Wen; Changchuan Jiang; Holly M Koncicki; Carol R Horowitz; Richard S Cooper; Aparna Saha; Steven G Coca; Girish N Nadkarni; Lili Chan Journal: J Am Soc Nephrol Date: 2019-08-06 Impact factor: 10.121
Authors: Marcus Sellars; Josephine M Clayton; Karen M Detering; Allison Tong; David Power; Rachael L Morton Journal: PLoS One Date: 2019-05-31 Impact factor: 3.240